+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Colon Cancer Drugs Market Research Reports

From
From
From
From
From
From
From
From
From
Metastatic Colorectal cancer - Pipeline Insight, 2022 - Product Thumbnail Image

Metastatic Colorectal cancer - Pipeline Insight, 2022

  • Drug Pipelines
  • March 2022
  • 200 Pages
From
From
From
Colorectal Cancer - Pipeline Insight, 2022 - Product Thumbnail Image

Colorectal Cancer - Pipeline Insight, 2022

  • Clinical Trials
  • February 2022
  • 160 Pages
From
Loading Indicator

Colon (or colorectal/bowel cancer) is diagnosed in over 1 million people annually, and accounts for over 0.5 million deaths each year. According to a recent article in the renowned Lancet medical journal, in Europe the 5-year survival for colorectal cancer is less than 60% so there is certainly considerable market potential for effective and accessible new pharmaceutical drugs. Reports in the Colon Cancer Section will help industry operators, and those considering entering this market, to answer the key questions such as what are the latest clinical trials, what are the R&D trends, what is the potential for personalized medicine, where are the opportunities in major markets such as China and the US, etc. Show Less Read more